Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma. 1994

P Iversen, and F Rasmussen, and I J Christensen
Department of Urology, Rigshospitalet, University of Copenhagen, Denmark.

In 245 patients with previously untreated advanced carcinoma of the prostate, serum concentrations of testosterone have been measured before androgen deprivation therapy, and patients were divided in quartiles according to their serum concentration. Pretreatment level of serum testosterone was confirmed as having significant prognostic value on progression-free, overall, and cancer-specific survival, and the hazard ratios of lower quartiles compared to the upper quartile for these endpoints were 2.3, 2.1, and 2.0, respectively. However, correlations with symptomatology and other pretreatment parameters suggest that low serum testosterone merely is a consequence of the advanced malignancy rather than a causative factor in the pathogenesis of prostatic cancer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone

Related Publications

P Iversen, and F Rasmussen, and I J Christensen
January 1992, European urology,
P Iversen, and F Rasmussen, and I J Christensen
February 1990, International journal of cancer,
P Iversen, and F Rasmussen, and I J Christensen
October 1981, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
P Iversen, and F Rasmussen, and I J Christensen
February 2007, Annals of surgical oncology,
P Iversen, and F Rasmussen, and I J Christensen
January 1991, The Prostate,
P Iversen, and F Rasmussen, and I J Christensen
January 2014, Hepatology (Baltimore, Md.),
P Iversen, and F Rasmussen, and I J Christensen
January 2023, Cancer control : journal of the Moffitt Cancer Center,
P Iversen, and F Rasmussen, and I J Christensen
August 1980, The Journal of urology,
P Iversen, and F Rasmussen, and I J Christensen
August 2008, Advances in therapy,
Copied contents to your clipboard!